Anbio Biotechnology (NNNN)Healthcare | Medical Instruments & Supplies | Frankfurt am Main, Germany | NasdaqGM
26.98 USD
-0.17
(-0.626%) ⇩
(April 20, 2026, 4 p.m.
EDT)
Short-term: ★★★☆☆ | Long-term: ☆☆☆☆☆ | Dividends: ☆☆☆☆☆ |
Hot Take | April 19, 2026, 12:07 a.m. EDT
Despite rich momentum indicators and a positive 45-day forecast, NNNN presents a severe value trap; the 181x P/E and -9.6M free cash flow render it uninvestable for the long term, with the recent price surge confirming the 'overvalued' label found in headlines. |
| Model | MAE |
|---|---|
| AutoTheta ✓ | 0.086482 |
| AutoETS | 0.133169 |
| AutoARIMA | 0.133173 |
| MSTL | 0.134238 |
Forecast horizon: 45 days | Selected: AutoTheta
| Forecast Reliability | |
|---|---|
| Score | 80% |
| H-stat | 0.27 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.466 |
| Excess Kurtosis | -0.79 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Revenue per Share | 0.198 |
| Market Cap | 1,184,184,576 |
| Trailing P/E | 179.87 |
| Profit Margins | 74.06% |
| Website | https://www.anbio.com |
| Attribute | Value |
|---|---|
| 52 Week Change | 2.9158201 |
| Address1 | Wilhelm Gutbrod Str 21B |
| All Time High | 55.65 |
| All Time Low | 5.18 |
| Ask | 27.35 |
| Ask Size | 2 |
| Average Daily Volume10 Day | 29,420 |
| Average Daily Volume3 Month | 55,440 |
| Average Volume | 55,440 |
| Average Volume10Days | 29,420 |
| Bid | 27.15 |
| Bid Size | 2 |
| Book Value | 0.687 |
| City | Frankfurt am Main |
| Compensation As Of Epoch Date | 1,735,603,200 |
| Country | Germany |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 26.98 |
| Current Ratio | 344.311 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,774,915,200 |
| Day High | 27.615 |
| Day Low | 26.52 |
| Earnings Timestamp End | 1,745,837,940 |
| Earnings Timestamp Start | 1,745,837,940 |
| Ebitda Margins | 0.0 |
| Enterprise To Revenue | 135.574 |
| Enterprise Value | 1,172,283,392 |
| Eps Trailing Twelve Months | 0.15 |
| Esg Populated | 0 |
| Exchange | NGM |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 24.6196 |
| Fifty Day Average Change | 2.3603992 |
| Fifty Day Average Change Percent | 0.0958748 |
| Fifty Two Week Change Percent | 291.582 |
| Fifty Two Week High | 55.65 |
| Fifty Two Week High Change | -28.670002 |
| Fifty Two Week High Change Percent | -0.5151842 |
| Fifty Two Week Low | 6.05 |
| Fifty Two Week Low Change | 20.93 |
| Fifty Two Week Low Change Percent | 3.4595041 |
| Fifty Two Week Range | 6.05 - 55.65 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,739,975,400,000 |
| Float Shares | 39,691,251 |
| Free Cashflow | -9,605,703 |
| Full Exchange Name | NasdaqGM |
| Full Time Employees | 27 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Gross Margins | 0.87236 |
| Gross Profits | 7,543,162 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.047849998 |
| Held Percent Institutions | 0.048520003 |
| Implied Shares Outstanding | 43,891,200 |
| Industry | Medical Instruments & Supplies |
| Industry Disp | Medical Instruments & Supplies |
| Industry Key | medical-instruments-supplies |
| Ipo Expected Date | 2,025-02-19 |
| Is Earnings Date Estimate | 0 |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Long Business Summary | Anbio Biotechnology provides in vitro diagnostics (IVD) products in the European Union, the Asia Pacific, North America, South America, Africa, and internationally. It offers SARS-CoV-2 antigen rapid and SARS-CoV-2/influenza A/B antigen rapid tests; and lateral flow immunoassay, fluorescence immunoassay, loop-mediated isothermal amplification, chemiluminescence immunoassay, and reverse-transcription polymerase chain reaction products. It serves over-the-counter, point-of-care testing, and laboratory markets. The company was incorporated in 2021 and is based in Frankfurt am Main, Germany. |
| Long Name | Anbio Biotechnology |
| Market | us_market |
| Market Cap | 1,184,184,576 |
| Market State | PRE |
| Max Age | 86,400 |
| Message Board Id | finmb_1914568067 |
| Most Recent Quarter | 1,767,139,200 |
| Net Income To Common | 6,403,463 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 1,184,184,576 |
| Open | 27.44 |
| Operating Cashflow | -6,739,075 |
| Operating Margins | 0.59093 |
| Payout Ratio | 0.0 |
| Phone | 49 16 0962 47281 |
| Previous Close | 27.15 |
| Price Hint | 2 |
| Price To Book | 39.272198 |
| Price To Sales Trailing12 Months | 136.94992 |
| Profit Margins | 0.74055 |
| Quick Ratio | 177.127 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | none |
| Region | US |
| Regular Market Change | -0.17 |
| Regular Market Change Percent | -0.626151 |
| Regular Market Day High | 27.615 |
| Regular Market Day Low | 26.52 |
| Regular Market Day Range | 26.52 - 27.615 |
| Regular Market Open | 27.44 |
| Regular Market Previous Close | 27.15 |
| Regular Market Price | 26.98 |
| Regular Market Time | 1,776,715,200 |
| Regular Market Volume | 21,812 |
| Return On Assets | 0.14664 |
| Return On Equity | 0.27049 |
| Revenue Growth | 0.739 |
| Revenue Per Share | 0.198 |
| Sand P52 Week Change | 0.34445214 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Shares Outstanding | 43,891,200 |
| Shares Percent Shares Out | 0.0007 |
| Shares Short | 30,509 |
| Shares Short Previous Month Date | 1,772,150,400 |
| Shares Short Prior Month | 49,220 |
| Short Name | Anbio Biotechnology |
| Short Percent Of Float | 0.0007 |
| Short Ratio | 0.83 |
| Source Interval | 15 |
| Symbol | NNNN |
| Total Cash | 11,901,231 |
| Total Cash Per Share | 0.271 |
| Total Debt | 0 |
| Total Revenue | 8,646,844 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | 0.15 |
| Trailing P E | 179.86665 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 32.53695 |
| Two Hundred Day Average Change | -5.5569496 |
| Two Hundred Day Average Change Percent | -0.1707889 |
| Type Disp | Equity |
| Volume | 21,812 |
| Website | https://www.anbio.com |
| Zip | 60,437 |